Back
First Trust NASDAQ Technology Div ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
55
TDIV
First Trust NASDAQ Technology Div ETF
Last Price:
81.04
Seasonality Move:
4.03%
Buy
72
ALGS
Aligos Therapeutics
Last Price:
34.24
Seasonality Move:
11.63%
Buy
55
First Trust NASDAQ Technology Div ETF (TDIV)
is a Buy
Is First Trust NASDAQ Technology Div ETF a Buy, Sell or Hold?
- The current First Trust NASDAQ Technology Div ETF [TDIV] share price is $79.88. The Score for TDIV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- TDIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TDIV Stock Price Chart
What is First Trust NASDAQ Technology Div ETF's stock price today?
-
The First Trust NASDAQ Technology Div ETF share price today is $79.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
TDIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 48.03 | Sell |
Chaikin Money Flow: | -131520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.24 - 81.28) | Sell |
Bollinger Bands (100): | (75.61 - 81.01) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.85 | Buy |
Relative Strength Index (14 RSI): | 78.88 | Buy |
Chaikin Money Flow: | -127407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.12 - 28.52) | Buy |
Bollinger Bands (100): | (7.57 - 20.11) | Buy |
TDIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.69 | Sell |
20-day SMA: | 80.01 | Sell |
50-day SMA: | 80.24 | Sell |
200-day SMA: | 75.06 | Buy |
8-day EMA: | 80.37 | Sell |
20-day EMA: | 80.29 | Sell |
50-day EMA: | 79.81 | Buy |
200-day EMA: | 74.93 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.4 | Buy |
20-day SMA: | 24.33 | Buy |
50-day SMA: | 15.25 | Buy |
200-day SMA: | 15.91 | Buy |
8-day EMA: | 29.74 | Buy |
20-day EMA: | 24.86 | Buy |
50-day EMA: | 18.75 | Buy |
200-day EMA: | 16.3 | Buy |
First Trust NASDAQ Technology Div ETF Earnings Growth & TDIV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
First Trust NASDAQ Technology Div ETF Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |